141 related articles for article (PubMed ID: 37624518)
1. Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based Study.
Sugumar K; Hue JJ; Gupta S; Elshami M; Rothermel LD; Ocuin LM; Ammori JB; Hardacre JM; Winter JM
Ann Surg Oncol; 2023 Dec; 30(13):8610-8620. PubMed ID: 37624518
[TBL] [Abstract][Full Text] [Related]
2. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare.
Pathak R; Leslie M; Dondapati P; Davis R; Tanaka K; Jett E; Chervoneva I; Tanaka T
Breast Cancer; 2023 Jul; 30(4):627-636. PubMed ID: 37130988
[TBL] [Abstract][Full Text] [Related]
3. Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands.
Zijlstra M; van der Geest LGM; van Laarhoven HWM; Lemmens VEPP; van de Poll-Franse LV; Raijmakers NJH
Acta Oncol; 2018 Sep; 57(9):1185-1191. PubMed ID: 29741436
[TBL] [Abstract][Full Text] [Related]
4. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing and treatment strategy for pancreatic cancer.
Gamboa AC; Rupji M; Switchenko JM; Lee RM; Turgeon MK; Meyer BI; Russell MC; Cardona K; Kooby DA; Maithel SK; Shah MM
J Surg Oncol; 2020 Sep; 122(3):457-468. PubMed ID: 32470166
[TBL] [Abstract][Full Text] [Related]
6. Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally.
Lutfi W; Zenati MS; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2018 Jul; 25(7):1860-1867. PubMed ID: 29691733
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern Era.
Hue JJ; Dorth J; Sugumar K; Hardacre JM; Ammori JB; Rothermel LD; Saltzman J; Mohamed A; Selfridge JE; Bajor D; Winter JM; Ocuin LM
Am Surg; 2021 Sep; 87(9):1386-1395. PubMed ID: 34382877
[TBL] [Abstract][Full Text] [Related]
8. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress?
Mellado S; Vega EA; Abudalou M; Kutlu OC; Salehi O; Li M; Kozyreva O; Freeman R; Conrad C
J Gastrointest Surg; 2022 Aug; 26(8):1-7. PubMed ID: 35508681
[TBL] [Abstract][Full Text] [Related]
9. Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.
Laurent-Badr Q; Barbe C; Brugel M; Hautefeuille V; Volet J; Grelet S; Desot E; Botsen D; Deguelte S; Pitta A; Abdelli N; Brasseur M; De Mestier L; Neuzillet C; Bouché O
Dig Liver Dis; 2020 Jun; 52(6):658-667. PubMed ID: 32362489
[TBL] [Abstract][Full Text] [Related]
10. Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinoma.
Sugumar K; Hue JJ; Hardacre JM; Ammori JB; Rothermel LD; Dorth J; Saltzman J; Mohamed A; Selfridge JE; Bajor D; Winter JM; Ocuin LM
HPB (Oxford); 2022 Apr; 24(4):433-442. PubMed ID: 34465529
[TBL] [Abstract][Full Text] [Related]
11. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States.
Ordonez JE; Hester CA; Zhu H; Augustine M; Porembka MR; Wang SC; Yopp AC; Mansour JC; Zeh HJ; Polanco PM
Ann Surg Oncol; 2020 Jun; 27(6):1997-2006. PubMed ID: 31894482
[TBL] [Abstract][Full Text] [Related]
13. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
[TBL] [Abstract][Full Text] [Related]
14. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
15. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.
Tohme S; Kaltenmeier C; Bou-Samra P; Varley PR; Tsung A
Ann Surg Oncol; 2018 Nov; 25(12):3427-3435. PubMed ID: 30043318
[TBL] [Abstract][Full Text] [Related]
16. Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.
Golan T; Sella T; O'Reilly EM; Katz MH; Epelbaum R; Kelsen DP; Borgida A; Maynard H; Kindler H; Friedmen E; Javle M; Gallinger S
Br J Cancer; 2017 Mar; 116(6):697-702. PubMed ID: 28183138
[TBL] [Abstract][Full Text] [Related]
17. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.
Amin S; Baine M; Meza J; Alam M; Lin C
Radiat Oncol; 2020 Jun; 15(1):139. PubMed ID: 32493354
[TBL] [Abstract][Full Text] [Related]
18. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
19. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
20. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]